Mesoblast (MESO) Other Operating Expenses (2015 - 2023)
Mesoblast (MESO) reported Other Operating Expenses of $972000.0 for Q2 2023, up 285.5% on a YoY basis from $252142.6 in Q2 2022, and down 70.7% sequentially from $3.3 million in Q1 2023.
Mesoblast (MESO) Other Operating Expenses (2015 - 2023) Analysis & Trends
Mesoblast (MESO) has 9 years of Other Operating Expenses data on file, last reported at $972000.0 in Q2 2023.
- For the quarter ending Q2 2023, Other Operating Expenses rose 285.5% year-over-year to $972000.0; the trailing twelve-month figure through Dec 2024 stood at $972000.0 (down 78.59% YoY), and the FY2025 full-year result was $3.1 million, up 18.79% from the prior year.
- Other Operating Expenses retreated to $972000.0 in Q2 2023, from $3.3 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $3.3 million in Q1 2023 to a low of -$524000.0 in Q2 2022.
- A 5-year average of $270833.3 and a median of $120000.0 in 2020 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses soared 1603.85% in 2020 and sank 471.63% in 2022, its largest moves.
- Tracing MESO's Other Operating Expenses over 5 years: stood at $143000.0 in 2019, then soared by 106.99% to $296000.0 in 2020, then plunged by 176.69% to -$227000.0 in 2021, then surged by 210.57% to $251000.0 in 2022, then jumped by 287.25% to $972000.0 in 2023.
- Business Quant data shows MESO's Other Operating Expenses at $972000.0 in Q2 2023, $3.3 million in Q1 2023, and $251000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 972,000.00 |
| Mar 31, 2023 | 3.32 Mn |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | -504,000.00 |
| Jun 30, 2022 | -524,000.00 |
| Mar 31, 2022 | 392,000.00 |
| Dec 31, 2021 | -227,000.00 |
| Sep 30, 2021 | -178,000.00 |
| Jun 30, 2021 | 141,000.00 |
| Mar 31, 2021 | 1.03 Mn |
| Dec 31, 2020 | 296,000.00 |
| Sep 30, 2020 | 99,000.00 |
| Jun 30, 2020 | 391,000.00 |
| Mar 31, 2020 | -442,000.00 |
| Dec 31, 2019 | 143,000.00 |
| Sep 30, 2019 | -169,000.00 |
| Jun 30, 2019 | -26,000.00 |
| Mar 31, 2019 | -82,000.00 |
| Dec 31, 2018 | -827,000.00 |
| Sep 30, 2018 | -151,000.00 |